MEMBERSHIP LOGIN
MEMBERSHIP LOGIN
Subscribe for PTCOG-NA Updates
Membership Portal
December 4, 2020. 10.15am to 2pm. All times shown in Eastern Standard Time (EST)
10.15 – 10:30
Dr Anita Mahajan (PTCOG-NA President) and Dr Brad Hoppe (PTCOG-NA Secretary)
Moderator: Dr Brad Hoppe
10:30 – 10:45
Dosimetric rationale and early clinical data on proton therapy for locally advanced Non-small cell lung cancer - Dr Joe Chang
10:45 – 11:00
Overview and lessons learned from Phase II and III Randomized controlled studies of proton therapy versus IMRT for locally advanced Non-small cell lung cancer - Dr Xing Liao
11:00 – 11:15
Rationale and outcomes for using proton therapy for post-operative stage II and III Non-small cell lung cancer - Dr Ramesh Rengan
11:15 – 11:30
Role of proton therapy in Small Cell Lung Cancer - Dr Chuck Simone
11:30 – 11:45
PT and Immunotherapy - Dr Abigail Berman
11:45 – 12:00
Future outlook of clinical trials in locally advanced lung cancer - Dr Jeff Bradley
12:00 - 12:15
Question / Discussion time
Moderator: Dr Stella Flampouri
12:15 – 13:45
Different institutional approaches to proton planning locally advanced lung cancer
MDACC approach - Prof Xiaorong Ronald Zhu
Northwestern approach - Dr Mark Pankuch